Cargando…
Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in rats
We focused on the relationship of 0.5% tetracaine- and 0.4% oxybuprocaine-induced corneal anesthesia in rats, and pentadecapeptide BPC 157 (0.4 µg/eye), along with nitric oxide synthase (NOS) inhibitor N(gamma)-nitro-L-arginine methyl ester (L-NAME) (0.1 mg/eye) and/or NOS substrate L-arginine (2 mg...
Autores principales: | Mirković, Ivan, Kralj, Tamara, Lozić, Marin, Stambolija, Vasilije, Kovačević, Josip, Vrdoljak, Luka, Zlatar, Mirna, Milanović, Kristina, Drmić, Domagoj, Predović, Jurica, Masnec, Sanja, Jurjević, Matija, Bušić, Mladen, Seiwerth, Sven, Kokot, Antonio, Sikirić, Predrag |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212645/ https://www.ncbi.nlm.nih.gov/pubmed/34177048 http://dx.doi.org/10.20471/acc.2020.59.03.02 |
Ejemplares similares
-
In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro
por: Lozic, Marin, et al.
Publicado: (2020) -
Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions
por: Sikiric, Predrag, et al.
Publicado: (2023) -
Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma
por: Kralj, Tamara, et al.
Publicado: (2021) -
BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats
por: Zlatar, Mirna, et al.
Publicado: (2021) -
Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats Treated with Pentadecapeptide BPC 157
por: Gamulin, Ozren, et al.
Publicado: (2022)